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EFFECTIVENESS OF THE BRAZILIAN INFLUENZA VACCINATION POLICY, A SYSTEMATIC REVIEW
Expedito J.A. LUNA(1) & Vera L. GATTÁS(2)
SUMMARY
Since 1999, Brazil has undertaken annual influenza vaccine campaigns, free of charge, targeting the elderly population, health 
professionals, and immune-deficient patients. We conducted a systematic review of literature in order to evaluate the effectiveness 
of the initiative. We used the keywords influenza, vaccine, Brazil and effectiveness to search the main databases. Thirty-one studies 
matched our inclusion and exclusion criteria. Influenza vaccine coverage among the elderly is high, though not as high as suggested 
by the official figures. Estimates on effectiveness are scarce. The majority come from ecological studies that show a modest reduction 
in mortality and hospital admissions due to influenza-related causes. Such reduction is not evident in the North and Northeastern states 
of Brazil, a finding that is probably related to the different seasonal pattern of influenza in equatorial and tropical regions. Brazilian 
epidemiologists still owe society better-designed studies addressing the effectiveness of influenza vaccine campaigns.
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INTRODUCTION
Since 1999, Brazil undertakes annual influenza vaccine campaigns 
targeting the elderly population, other groups vulnerable to influenza 
complications, and health professionals. The flu vaccine has been 
provided, free of charge, in national campaigns, which usually have 
been held in late April/ early May. In 1999, the campaign targeted the 
population over 65 years of age. Since 2000 it has targeted the population 
over 60. Influenza vaccination campaigns have been regarded as largely 
successful, reaching high vaccine coverage (Fig. 1) among the elderly, 
the largest group included in the initiative.
Fig. 1 - Influenza Vaccine coverage among the population > 60 years of age, Brazil - 1999 
to 2009.*
According to the Ministry of Health (MOH) figures, coverage has 
reached the 70% target among the elderly population in all years, except 
2000. MOH does not present figures on vaccine coverage in other groups 
targeted in the flu vaccine campaigns (health care workers, transplant 
patients, people living with immune deficiencies, and other groups of 
high risk patients for influenza complications), because of the alleged 
lack of denominators for the coverage calculus.
In spite of such apparent success, little is known about the 
effectiveness of the initiative. We have conducted a systematic review 
regarding the effectiveness of the Brazilian influenza vaccine, in order 
to clarify what has already been established on the subject, and what 
remains to be understood.
METHODS
We conducted a systematic review of literature on influenza vaccine 
effectiveness studies in Brazil, using the keywords influenza, Brazil, 
vaccine, and effectiveness in different combinations. We searched 
in Medline, PubMed, Lilacs, BVS and Scielo, with no restriction on 
publication dates. We used as inclusion criteria any study that analyzed 
the Brazilian influenza vaccine policy. As exclusion criteria: any study 
published before 1999, clinical trials carried out in Brazil, evaluation of 
influenza vaccine in occupational settings outside the Brazilian policy, 
outbreak investigations, and papers on laboratory methods. The searches 
were done between September 2009 and May 2010. By systematically 
reviewing published data, we aim to provide better estimates of influenza 
vaccination effectiveness in Brazil and the factors related to it. The 
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recovered articles were first selected on the basis of publication year: the 
Brazilian vaccination policy was introduced in 1999, so papers published 
before that year could not have evaluated it. After we analyzed their titles 
to confirm they were related to the issues of interest, and later, their 
abstracts were analyzed, to reassure that they addressed the effectiveness 
of the Brazilian vaccination policy or any factors related to it. Once the 
articles were selected, we reviewed their reference lists, in order to find 
other articles that might have been missed in our databases search. In 
this latter step, we have also included some unpublished papers that were 
considered relevant, such as academic studies (dissertations, theses) and 
reports from public health authorities.
RESULTS
We found 380 articles that matched our search criteria. We then 
analyzed the list, excluding the ones that were published before the 
beginning of the Brazilian influenza vaccination campaigns (1999), 
those that were not actually related to Brazil (some referred to the Brazil 
influenza B viral subtype), and a few others that did not address the 
issues of interest (Fig. 2). 51 papers were selected as potentially relevant.
We then re-analyzed these papers’ abstracts, to ensure they addressed 
the issue of interest, and when necessary, the whole article was analyzed. 
20 more articles were excluded. Elimination was based on the exclusion 
criteria, and the evaluation of the issues actually covered by the abstracts 
and articles. For instance, some of the excluded papers were reports 
of clinical trial results of new influenza vaccines, conducted in Brazil; 
some others addressed vaccine effectiveness in occupational settings not 
covered by the national policy; some presented outbreak investigations, 
or either laboratorial diagnosis. Some unpublished studies (n = 3) were 
found during the analysis of the selected papers’ lists of references. 
Eventually, 31 papers were selected. Selected articles were then classified 
in 5 categories (Fig. 3):
1) Articles that presented data on influenza vaccine coverage.
2) Articles addressing the seasonality of influenza in Brazil.
3) Articles on vaccine effectiveness, using an ecological approach.
4) Articles on vaccine effectiveness with individual based study designs.
5) Review articles.
Vaccine coverage: fourteen studies presented survey data on vaccine 
coverage. Among them, four evaluated vaccine coverage among health 
professionals and/or immune-deficient patients (Table 1). Among health 
professionals, two surveys conducted in two of the leading university 
hospitals in the country presented coverage of 19.7% and 34.4%4,33. In 
the same institutions, vaccine coverage among transplant patients varied 
between 44.2% (bone marrow transplant) and 0% (kidney)5,25. The other 
ten studies analyzed vaccine coverage among the senior population. 
The majority of them were surveys conducted in representative samples 
of the target population,7,9,13,16,17,20,24 and the remaining three among 
outpatients of a primary care clinic and reference hospitals22,23,30. Five 
surveys detected vaccine coverage similar to the Ministry of Health’s 
(MOH) administrative data9,13,16,17,30. On the other hand, large differences 
were observed by the other three: among the elderly of two low income 
communities (“favelas”) in the city of Rio de Janeiro, survey coverage 
was 50.2% and 38.3%, compared to MOH 75.7% coverage for the whole 
city; 66.3% coverage in Belo Horizonte, the country’s third largest 
city, compared to 85.5% according to MOH data; and 83.8% among 
outpatients of a primary care clinic in Botucatu, state of São Paulo, 
compared to 62.2% (MOH)7,22,24.
Ecologic studies: Thirteen of the recovered studies evaluated the 
Brazilian vaccine strategy effectiveness using an ecological design. 
Three additional studies used the same design to address influenza 
seasonality in Brazil. Table 2 presents a summary of these studies. Seven 
studies analyzed mortality data time series,2,3,8,12,18,21,26 while five analyzed 
hospital admissions data6,11,15,19,31. One study used both mortality and 
morbidity data14. Two others analyzed time series of laboratory-confirmed 
influenza cases to discuss seasonality27,28. Mortality studies have been 
used as outcomes to influenza-related death causes, which usually include 
influenza, pneumonia and obstructive respiratory diseases. Their analysis 
included different time series, and also different geographic units (the 
whole country, a state, a municipality), and comparison of pre- and 
post-vaccination mortality rates were made using different time frames. 
Some studies found a decrease in influenza-related mortality, while some 
others found the opposite trend. A decrease in influenza-related mortality 
was more evident in Southern states, and even the studies that found an 
overall increase in rates showed a reduction in peaks of mortality after the 
introduction of mass vaccine campaigns, a phenomenon that was more 
pronounced in Southern states. One study analyzed the effect of influenza 
vaccination upon mortality due to ischemic heart disease (IHD). The study 
found a significant reduction of IHD mortality after the introduction of the 
mass vaccination of the elderly26. Influenza morbidity studies have used 
data from SIH-SUS, the hospital admissions database of the Brazilian 
Public Health System (SUS), which accounts for 80% of the country’s 
Fig. 2 - Systematic review flowchart.
Fig. 3 - Syatematic review results. 
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Table 1 
Influenza vaccine coverage and effectiveness studies in Brazil, 1999 - 2009
Reference Place Time Vaccinated group Survey’ vaccine 
coverage
MOH vaccine 
coverage
Bellei et al., 20074 São Paulo 2001 - 2003 Health professionals 19.7% - a
Bellei et al., 20075 São Paulo 2001 - 2003 Health professionals and 
transplant patients
19.7% and 0% - a
Cabral, 20067 Rio de Janeiro, two 
communities
2004 Population > 60 years of age 50.2% and 38.3% 75.7% (Municipality 
of Rio de Janeiro)
Cesar et al., 20089 Municipalities of 
Caracol and Garrafão 
do Norte
2005 Population > 60 years of age 80.2% and 88.1% 87.5% and 99.9%
Donalisio et al., 
200613
Botucatu 2003 Population > 60 years of age 63.2% 70%
Francisco et al., 
200616
6 municipalities in the 
State of São Paulo
2001 - 2002 Population > 60 years of age 66% 66.3% (2001) and 
62% (2002)
Francisco et al., 
200617
6 municipalities in the 
State of São Paulo
2001 - 2002 Population > 60 years of age 66.3% (2001) and 
62% (2002)
64.3%
Francisco et al., 
200620
5 municipalities in the 
State of São Paulo
2001 - 2002 Population > 60 years of age 66.9% and 67.6% in 
the different sample 
strata
64.3%
Geronutti et al., 200822 Botucatu 2006 Population > 60 years of age, 
attending a primary care clinic
83.8% 62.2%
Gutierrez et al., 200123 São Paulo 1999 Population > 60 years of age, 
attending a reference hospital
70.1% 79.3%
Lima-Costa, 200824 Belo Horizonte 2003 Population > 60 years of age 66.3% 85.5%
Machado et al., 200525 São Paulo 2001 - 2002 Bone marrow transplant 
patients
44.2% - a
Santos et al., 200930 Porto Alegre 2006 Population > 60 years of age, 
attending a reference hospital
76.5% 72.5%
Takayanagi et al., 
200733
São Paulo 2002 Health professionals 34.4% - a
a - The Ministry of Heath does not provide data on influenza vaccine coverage for health professionals or immune-deficient patients, for alleged lack of denominator 
for calculus.
hospital admissions. The overall pattern of influenza-related hospital 
admissions is similar to that of mortality studies. Some studies show a 
reduction in hospital admissions, more pronounced in Southern states, 
while others point to an increase in influenza-related hospitalizations, 
especially in North and Northeastern states.
Seasonality: influenza seasonality has been addressed by the analysis 
of mortality and morbidity data, and also of laboratorial surveillance 
data. When morbidity and mortality data are analyzed together, a 
marked peak of influenza-related mortality and morbidity in South and 
Southeastern states in late autumn/early winter months become evident, 
while seasonality is not so evident in North and Northeastern regions28,29,30. 
One study concluded that influenza activity in the North peaks earlier in 
the year, and heads South as it gradually shifts to the winter months, a 
movement that has been described by authors as a “seasonal southward 
traveling wave, originating in equatorial and low-populated regions in 
March-April, and moving towards temperate and highly populous regions 
in a three-month period”1.
Studies using an individualized design: only two of the recovered 
studies analyzed the Brazilian vaccination strategy using an individually-
based design23,25. A cross-sectional study conducted early in the course 
of the initiative in 2000, targeted the elderly clientele of the largest 
university hospital complex in the country. Patients that came to receive 
the influenza vaccine were invited to participate, and asked if they had 
been vaccinated against influenza the year before and whether they 
had presented episodes of influenza-like illness (ILI) during the year. 
The proportion that indicated at least one ILI episode was 45% among 
those vaccinated, and 48% among the non-vaccinated (p = 0.69). The 
mean number of ILI episodes reported during the year was 1.5 among 
vaccinated subjects and 2.25 among non-vaccinated (p = 0.019)23. Another 
study analyzed the effectiveness of the vaccination of transplant patients25.
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Finally, we included one review article, published in 2005, which 
addressed part of the issues we intend to discuss in the present paper, 
when the number of published papers on these issues was much 
smaller10.
DISCUSSION
A number of factors might influence the effectiveness of an influenza 
vaccination strategy. Among them, we may cite vaccine coverage, vaccine 
“match”, and the methodological issues related to the way effectiveness 
itself is defined and measured.
Concerning vaccine coverage, the Brazilian MOH administrative 
data shows coverage above the 70% target in all years but one since the 
beginning of the initiative. According to MOH, coverage tends to be 
higher in North and Northeastern states, and lower in the other regions 
of the country. Independent survey data cannot be directly compared 
with national figures, as they usually address smaller geographic units, 
Table 2 
Ecological studies addressing influenza vaccine effectiveness and influenza seasonality, Brazil, 1999 – 2009 
Reference Place Time Outcome Main findings
Alonso et al., 20071 Brazil 1979 - 2001 Pneumonia and influenza monthly 
mortality rates for each Brazilian 
state
Seasonality most pronounced 
in Southern states; a seasonal 
southward wave was identified
Antunes et al., 20072 Municipality of Sao 
Paulo
2 periods: 
1993 - 1997 and 
1998 - 2002
Pneumonia and influenza 
mortality rates among > 65 y
26.2% reduction in pneumonia 
and influenza mortality rates
Barbosa, 20063 Municipality of Sao 
Paulo
1991 - 2004 Pneumonia and influenza 
mortality rates among > 60 y
Increasing pneumonia and 
influenza mortality rates, from 
2001 to 2004
Brondi et al., 20006 Brazil 1998 - 2000 Pneumonia and influenza hospital 
admissions rates among > 60 y
Reduction in peaks of excess 
mortality in Southern states. 
Campagna et al., 20098 Brazil 1992 - 2005 Mortality rates for influenza 
related causes among > 60 y
Increase in mortality rates. 
Decrease of the amplitude of 
peaks in Southern states.
Daufenbach et al., 200911 Brazil 1992 - 2006 Hospital admissions rates for 
influenza related causes among 
> 60 y
Reduction in rates, most 
pronounced in Southern states
Donalisio et al., 200612 State of São Paulo 1980 - 2004 Mortality rates for influenza 
related causes among > 60 y
Increase in mortality rates after 
2002
Façanha, 200514 Municipality of 
Fortaleza
1992 - 2003 Hospital admissions and mortality 
rates for respiratory and heart 
diseases among > 60 y
No change in rates after the 
introduction of vaccine
Ferrer et al., 200815 State of Parana 1995 - 2005 Hospital admissions rates for 
respiratory diseases among > 60 y
Decreasing tendency in 
hospitalizations in both genders 
Francisco et al., 200518 State of Sao Paulo 1980 - 2000 Mortality rates for influenza 
related causes among > 60 y
Reduction in mortality rates
Francisco et al., 200419 State of Sao Paulo 1995 - 2002 Hospital admissions rates for 
respiratory diseases among > 60 y
Reduction in peaks of 
hospitalizations rates
Freitas, 200421 Brazil 1996 - 2001 Mortality rates for influenza 
related causes among > 60 y
Reduction in mortality rates 
in Southern, Southeastern and 
Central states
Mansur et al., 200926 Metropolitan Region 
of Sao Paulo
1980 - 2006 Mortality rates for ischemic heart 
disease 
Significant reduction in mortality 
rates
Mello et al., 200927 Cities of Belem and 
Sao Paulo
1999 - 2007 Influenza virus isolates Different scenarios using 
Northern or Southern hemisphere 
vaccine
Moura et al., 200928 City of Fortaleza 2001- 2007 Laboratory-based surveillance 
data
Peak incidence coincides with 
rainy season
Silvestre, 200231 Brazil 1999 - 2001 Hospital admissions for influenza 
related causes among > 60 y
Reduction in total number of 
hospital admissions for influenza 
related causes
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or just the clientele of some outpatient clinics. In spite of the differences 
in coverage between survey and MOH data, the former seem to confirm 
the latter. Surveys have observed coverage typically above 60%, higher 
in the Northeast and lower in South/Southeastern states.
Another factor that might influence vaccine effectiveness is the extent 
to which vaccine viral subtypes components match the influenza virus 
circulating in the population during the same season. Published data on 
laboratory surveillance of the influenza virus in Brazil are quite limited. 
In fact, only one paper in our review addressed vaccine match. Using data 
on viral isolates from two of the influenza national reference laboratories, 
located in the Amazon region (Belém) and in the Southeastern region 
(São Paulo), the authors discuss different scenarios that would increase 
effectiveness of national influenza vaccine campaigns. Viral subtypes 
that have circulated in Brazil show a similar match with both Northern 
and Southern hemisphere vaccine composition. According to the study, 
the use of the Southern hemisphere formulation earlier than currently 
scheduled (in January) or the use of the Northern hemisphere formulation 
would both increase the campaign’s success27.
As presented before, only two studies used individually-based study 
designs to evaluate influenza vaccine campaigns in Brazil. The first 
one found a significant difference in the mean number of reported ILI 
episodes between the vaccinated and the non-vaccinated13. The other 
study evaluated the effectiveness of the influenza vaccine in bone marrow 
transplant recipients, using a laboratory which confirmed influenza as 
the outcome variable. Vaccine effectiveness was estimated at 80%25. 
Morbidity and mortality ecological studies addressing the effectiveness of 
influenza vaccine campaigns have produced conflicting results. One study 
failed to demonstrate the effect of the vaccination in hospital admissions 
and mortality due to influenza-related causes,14 another found a 26% 
reduction in mortality rates due to influenza and pneumonia,2 and three 
studies point to an increase in influenza-related mortality rates3,8,12. Of the 
six studies analyzing hospital admissions, five found modest reductions 
in rates or number of hospitalizations,6,11,15,19,31 and the previously cited 
one showed no effect of the vaccination14. A large part of this apparent 
conflict might be explained by the differences in the time frames that 
were compared, in the geographic regions studied, in the presence 
or absence of rate standardization, and also in the outcome variables 
defined. As laboratory diagnosis of influenza is not routinely carried 
out, the majority of ecological studies use the category of influenza-
related morbidity and mortality causes as a proxy variable. Definitions 
of influenza-related causes are not standardized, and the different studies 
have used more or less inclusive definitions. In the particular case of 
Brazil, another factor that might have influenced mortality studies is the 
increasing coverage of the National Mortality Statistics System (SIM) 
and its ongoing improvement of information into the causes of death, 
with a marked reduction in the proportion of ill-defined mortality causes. 
This reduction is more pronounced in the less developed regions of the 
country, the North and Northeast, and might be held responsible for the 
increase in specified death causes, such as the ones related to influenza. 
One study showed a significant reduction in ischemic heart disease 
mortality, when compared to mortality due to cerebrovascular disease 
and external causes26.
In fact, mortality reduction benefits as a result of influenza vaccination 
are the subject of intense debate. The use of non-specific endpoints and 
the attribution of a large proportion of winter deaths to influenza have 
been deemed responsible for exaggerating the benefits of vaccination32. 
Nichol postulates that ecological studies on influenza mortality often 
assume that the ratio of excess deaths/winter-time deaths is approximately 
equal to the ratio of influenza-associated deaths/influenza season deaths. 
By doing so, most studies underestimate the numerator and overestimate 
the denominator, and produce false estimates of effectiveness29.
Besides the non-specific endpoints, ecological studies on influenza-
related morbidity and mortality use average measures that attribute to 
individuals characteristics of the group, and show associations that might 
not be valid at an individual level, the so-called ecological fallacy.
An additional factor that has influenced the Brazilian ecological 
studies is the distinct pattern of influenza seasonality in the country. 
Using mortality data,1 ALONSO et al. have demonstrated that seasonal 
pattern of influenza-related mortality is different as one moves from 
Northern to Southern Brazil. Influenza-related mortality peaks occur 
earlier in the year in the equatorial regions of Brazil, and later as one 
moves southwards. As influenza vaccine campaigns are scheduled in late 
April/ early March every year, they have been held after influenza peak 
season in Northern and most Northeastern Brazilian states, which might 
have reduced the effectiveness of vaccine campaigns and influenced the 
results of ecological studies. In fact, all studies suggest no reduction 
in influenza-related mortality and hospital admissions in Northern and 
Northeastern Brazilian states following influenza vaccine campaigns. 
National results have probably been influenced by these regions’ ones, 
reducing the campaign´s expected benefits. Paradoxically, vaccine 
coverage has been higher in the regions where less benefit would be 
expected, due to the scheduling of the campaigns.
The only review article included in the present selection discussed 
the caveats of influenza vaccination of the elderly in Brazil10. The authors 
recognize the paucity of data on influenza burden the country, especially 
for Northern regions, where influenza seasonality is not so evident, 
and also the limited number of studies on the impact of vaccination 
campaigns. Considering that “no reduction in disease burden is observed 
in all Brazilian regions”, they question if the current vaccine schedule is 
justifiable, and advocate for the improvement of influenza surveillance 
in Brazil.
Our systematic review on the effectiveness of influenza vaccine mass 
campaigns conducted in Brazil since 1999 has provided evidence that 
influenza vaccine coverage among the elderly is high, although not so high 
as presented by the official figures. Estimates on effectiveness are scarce. 
The majority of them come from ecological studies that show a modest 
reduction in mortality and hospital admissions due to influenza-related 
causes. Such reduction is not evident in the North and Northeastern states 
of Brazil, a finding that is probably related to the different seasonal pattern 
of influenza in equatorial and tropical regions. A change in vaccination 
schedule, with the anticipation of campaigns in North and Northeastern 
regions of the country, should be seriously considered, using either the 
Southern or Northern hemisphere vaccine. Most studies did not quantify 
the observed tendencies in mortality and hospital admissions.
In 2010, Brazil is conducting one of the largest influenza vaccine 
campaigns ever and Brazilian epidemiologists still owe society better-
designed studies to address the effectiveness of influenza vaccine 
campaigns.
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RESUMO
Efetividade da política brasileira de vacinação contra influenza, 
uma revisão sistemática
Desde 1999 o Brasil realiza campanhas anuais de vacinação contra 
influenza. A vacinação é gratuita, e tem como grupos alvo os idosos, os 
profissionais de saúde e os pacientes com comprometimento imunitário. 
Nós realizamos uma revisão sistemática da literatura, com o propósito 
de avaliar a efetividade desta iniciativa. Foram usadas as palavras chave 
influenza, vacina, Brasil e efetividade, para a busca nas bases de dados 
mais relevantes. Trinta e um estudos se encaixaram nos nossos critérios 
de inclusão e exclusão. A cobertura vacinal nos idosos é alta, porém não 
tão alta como apresentado nos dados oficiais. Estimativas de efetividade 
são escassas. A maioria delas vem de estudos ecológicos, que demonstram 
um modesto efeito na redução da mortalidade e internações hospitalares 
por causas relacionadas à influenza. Esta redução não se evidencia 
nos estados do Norte e Nordeste do Brasil, achado que provavelmente 
relaciona-se ao padrão distinto de sazonalidade da influenza nas regiões 
equatoriais e tropicais. Os epidemiologistas brasileiros ainda devem à 
sociedade estudos com desenhos mais adequados à análise da efetividade 
das campanhas de vacinação contra influenza.
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